Clinical Trial Update: An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase Ib/II trial of BAY 1000394 (roniciclib) in combination with Docetaxel for second- or third-line advanced non-small cell lung cancer has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Roniciclib (roniciclib)

Snippet

Sponsor: Yonsei University | Conditions: NSCLC (Non-Small Cell Lung Cancer) | Phase 1, Phase 2 | Status: WITHDRAWN